Marc Le Bozec
Direktor/Vorstandsmitglied bei NH THERAGUIX SAS
Ursprung des Netzwerks ersten Grades von Marc Le Bozec
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
34
| Non-Profit Organization | Miscellaneous Commercial Services | 34 |
Financière Arbevel SA
Financière Arbevel SA Investment ManagersFinance Financière Arbevel SA is an independent asset management firm headquartered in Paris, France. The firm was founded in 1997 and manages small and medium-sized French and European funds. Financière Arbevel is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI) which integrates environmental, social, and governance considerations into their investment process.
27
| Private Company | Investment Managers | 27 |
Public Company | Pharmaceuticals: Major | 15 | |
Holding Company | Pharmaceuticals: Major | 12 | |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France.
7
| Holding Company | Medical Specialties | 7 |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation.
7
| Holding Company | Medical Specialties | 7 |
Keranova SA
Keranova SA Medical SpecialtiesHealth Technology Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France.
6
| Holding Company | Medical Specialties | 6 |
Transcure Bioservices SAS
Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Scipio Bioscience SAS
Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Scipio Bioscience SAS operates as a biotechnology company. It provides a novel sample preparation solution for single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics. The company was founded by Pierre Walrafen and Stuart Edelstein on August 2, 2017 and is headquartered in Paris, France.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
NG Biotech SAS
NG Biotech SAS Medical SpecialtiesHealth Technology NG Biotech SAS is a French family-owned company founded in 2012 by a pioneer of the rapid test industry. The private company is based in Guipry-Messac, France. The company designs and manufactures innovative in vitro diagnostic tools suitable for decision making in medical emergencies, in the laboratory, and at the bedside. NG Biotech's innovation capabilities are powered by an expert R&D team backed by public-private scientific collaborations. The company proposes rapid tests in three main areas\: antimicrobial resistance, infectious disease (including COVID-19 tests), and women's health (blood pregnancy self-tests). NG Biotech's products are available in more than 70 countries, including the USA. The CEO is Milovan Stankov-Pugès.
1
| Private Company | Medical Specialties | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marc Le Bozec
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Auriga Partners SA
Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Investment Managers | Founder Director/Board Member Director/Board Member Private Equity Investor Private Equity Analyst | |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | President Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Availpro SAS
Availpro SAS Other Consumer ServicesConsumer Services Availpro SAS provides online hotel reservation solutions. It offers a booking engine, which is integrated with a distribution tool, allowing the hoteliers to advertise and sell their rooms on third party websites. The company was founded by Philippe Jean Pierre Lamarche and Sébastien Maurice Boher on April 6, 2001 and is headquartered in Paris, France. | Other Consumer Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member General Counsel Chief Executive Officer | |
Isocell SA
Isocell SA Food RetailRetail Trade Isocell SA operates as a holding company with interests in the manufacture of food supplements. It develops proprietary formulation for super-oxyde dismutase. The firm also targets food areas including sodas, sport drinks and dairies with wellness claims. It also engages in the ownership and operations of medical laboratories. The company was founded by Francois Vix on July 9, 2001 and is headquartered in Paris, France. | Food Retail | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
THERANEXUS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Director/Board Member | |
Tc Land Expression SA
Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Operating Officer Director/Board Member | |
BonitaSoft SA
BonitaSoft SA Packaged SoftwareTechnology Services BonitaSoft SA develops open source software. It also provides open source business process management solutions. The firm's product, Bonita open solution, is an open source BPM solution that designs, develops, executes, and monitors business processes; Bonita Studio, a BPM notation solution for drawing processes graphically; and Bonita execution engine with Bonita open solution for integrating new services or BPM standards as they emerge. The company was founded by Rodrigue Le Gall, Charles Souillard, and Miguel Valdes-Faura in 2001 and is headquartered in Boulogne, France. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Convertigo SA
Convertigo SA Packaged SoftwareTechnology Services Convertigo SAS provides Internet related software. It delivers a secured and scalable disruptive all-in-one solution, integrating rapid cross platform mobile development tools and a powerful MBaaS covering challenging backend enablement, featuring a middleware optimized for mobility. The company was founded by Olivier Picciotto and Jean-Michel Cohen in 1994 and is headquartered in Orsay, France. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
eXo Platform SAS
eXo Platform SAS Packaged SoftwareTechnology Services eXo Platform SAS provides information technology products and services. Its offers private cloud hosting, professional services, on-demand services, services packages, and training. The company was founded by Benjamin Mestrallet in 2003 and is headquartered in Paris, France. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
EnobraQ SAS
EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
MEDIAN TECHNOLOGIES | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
MILIBOO | Home Furnishings | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
UroMems SAS
UroMems SAS Medical SpecialtiesHealth Technology UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
École Normale Supérieure | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst | |
Pylote SA
Pylote SA BiotechnologyHealth Technology Pylote SA conceives and develops mineral microspheres to sell solutions. Its products include mineral microspheres, material integration and pylote added. The company was founded by Loïc Marchin and is headquartered in Dremil-Lafage, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
SANOFI | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Quilvest Asset Management SA (France)
Quilvest Asset Management SA (France) Investment ManagersFinance Quilvest Asset Management SA (France) (Quilvest France) is the French asset management division of Quilvest Asset Management S.A., ultimately held by Quilvest SA (LU: QUILV) in Luxembourg. Established in 1993, the firm is based in Paris and manages funds and traditional asset management mandates for insurance companies, pension funds, banks, asset management companies and high-net worth individuals. Quilvest France is a socially responsible investor which follows the UN Principles for Responsible Investment and considers ESG issues in their investment analysis and decision making processes. | Investment Managers | Analyst-Fixed Income Head-Fixed Income Invts Analyst-Fixed Income | |
EKINOPS | Telecommunications Equipment | Director/Board Member Director/Board Member Director/Board Member | |
Citigroup Global Markets Ltd. (France) | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Aveni SA
Aveni SA Chemicals: Major DiversifiedProcess Industries Aveni SA designs, develops, manufactures and markets chemical formulations. It enables future technologies with its approach to metallization for semiconductor, MEMS, advanced packaging, and flex applications. The company was founded in 2001 and is headquartered in Massy, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member Director/Board Member | |
AMOÉBA | Household/Personal Care | Director/Board Member Director/Board Member Director/Board Member | |
École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
WALLIX GROUP | Packaged Software | Chairman Director/Board Member Director/Board Member | |
Oddo BHF SCA (Broker)
Oddo BHF SCA (Broker) Investment Banks/BrokersFinance Oddo BHF SCA (Broker) is the securities brokerage division of Oddo BHF SCA, a financial services company headquartered in Paris, France. The firm provides equity brokerage services to various investors. | Investment Banks/Brokers | Market Strategist Analyst-Fixed Income Analyst-Equity | |
INSEAD | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
THERADIAG | Medical Specialties | Chairman Director/Board Member Chief Executive Officer | |
CELLNOVO | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
iDbyMe SA
iDbyMe SA Catalog/Specialty DistributionRetail Trade iDbyMe SA sells clothes online. It provides online shopping related services. The firm offers sweaters, short cardigans, long and short vests, shirts, leather jackets, tops, dresses and coats. It provides to its customers the possibility to submit their own clothing designs. The company is headquartered in Luxembourg. | Catalog/Specialty Distribution | Director/Board Member Director/Board Member Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
AFFLUENT MEDICAL | Medical Specialties | Chief Executive Officer Chairman | |
AlchiMedics SA
AlchiMedics SA Chemicals: Major DiversifiedProcess Industries AlchiMedics SA specializes in coating technologies via electrografting. Its products enables covalent adhesion of nano to micrometric polymer-based layers on surfaces. The firm designs, develops and implements electro-grafting technology for implantable biomedical applications. The company was founded in 2007 and is headquartered in Grenoble, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
CorWave SA
CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
PHARNEXT SCA | Biotechnology | Director of Finance/CFO Director/Board Member |
Statistik
International
Frankreich | 48 |
Vereinigtes Königreich | 2 |
Vereinigte Staaten | 2 |
Luxemburg | 2 |
Sektoral
Health Technology | 17 |
Consumer Services | 9 |
Finance | 7 |
Commercial Services | 5 |
Technology Services | 5 |
Operativ
Director/Board Member | 402 |
Chairman | 85 |
Corporate Officer/Principal | 82 |
Chief Executive Officer | 62 |
Founder | 47 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Philippe Peltier | 45 |
Célia Hart | 36 |
Florian Denis | 35 |
Sébastien Descarpentries | 29 |
Pierre Bastid | 29 |
Franck Lescure | 28 |
Philippe Archinard | 24 |
Philippe Boucheron | 24 |
Mathieu Simon | 22 |
Laurent Arthaud | 21 |
Hervé Eloi Dominique Brailly | 20 |
Thibaut Roulon | 18 |
Stéphane Legastelois | 16 |
Maryvonne Hiance | 15 |
Michel Finance | 15 |
- Börse
- Insiders
- Marc Le Bozec
- Unternehmensverbindungen